Application of the ORBIT Protocol for Targeted Gene Deletion to Mycobacterium abscessus
- 1Rutgers Health
Abstract
Mycobacterium abscessus (Mab) is an emerging opportunistic pathogen characterized by extensive intrinsic drug resistance, underscoring the need for precise genetic tools to define mechanisms of pathogenicity and persistence. The ORBIT (oligonucleotide-mediated recombineering followed by Bxb1 integrase targeting) system developed by the Sassetti group enables precise gene deletions but has primarily been optimized for Mycobacterium tuberculosis and Mycobacterium smegmatis. Although ORBIT has been used in Mab, here we describe an optimized ORBIT workflow for efficient gene deletion in Mab. We tested key parameters, including plasmid selection, oligonucleotide design, and recombineering conditions. We evaluated oligonucleotide length and purification to improve recovery of targeted mutants and established conditions that enabled reproducible deletion of multiple target genes. Our findings establish a robust and adaptable ORBIT protocol tailored to the genetic characteristics of Mab. This optimized workflow provides a practical framework for precise genetic manipulation and can facilitate functional studies of genes that contribute to Mab physiology, antimicrobial resistance, and pathogenesis.
Related
- Genome-wide evolutionary shifts shape the emergence of dominant circulating clones in Mycobacterium abscessus
- Modifications to a vegan artificial honey result in inhibitory activity against Mycobacterium abscessus
- Cryo-electron microscopy structure of Jabs, a bacteriophage infecting the multidrug-resistant pathogen Mycobacterium abscessus
- Iron-sulfur cluster delivery by SufT enables oxidative stress resistance and intracellular survival in Mycobacterium abscessus
- Comparing subsampling strategies for efficient pairwise analysis of large pathogen genomic and spatial datasets: An application to Mycobacterium tuberculosis transmission
BibTeX
@misc{amin2026application,
title = {{Application of the ORBIT Protocol for Targeted Gene Deletion to Mycobacterium abscessus}},
author = {N. H. Amin and T. W. Sherrier and N. A. Woychik},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.23.761380},
url = {https://www.biorxiv.org/content/10.64898/2026.10.23.761380v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Application of the ORBIT Protocol for Targeted Gene Deletion to Mycobacterium abscessus
AU - N. H. Amin
AU - T. W. Sherrier
AU - N. A. Woychik
PY - 2026
DA - 2026/10/23
PB - bioRxiv
DO - 10.64898/2026.10.23.761380
UR - https://www.biorxiv.org/content/10.64898/2026.10.23.761380v1
AB - Mycobacterium abscessus (Mab) is an emerging opportunistic pathogen characterized by extensive intrinsic drug resistance, underscoring the need for precise genetic tools to define mechanisms of pathogenicity and persistence. The ORBIT (oligonucleotide-mediated recombineering followed by Bxb1 integrase targeting) system developed by the Sassetti group enables precise gene deletions but has primarily been optimized for Mycobacterium tuberculosis and Mycobacterium smegmatis. Although ORBIT has been used in Mab, here we describe an optimized ORBIT workflow for efficient gene deletion in Mab. We tested key parameters, including plasmid selection, oligonucleotide design, and recombineering conditions. We evaluated oligonucleotide length and purification to improve recovery of targeted mutants and established conditions that enabled reproducible deletion of multiple target genes. Our findings establish a robust and adaptable ORBIT protocol tailored to the genetic characteristics of Mab. This optimized workflow provides a practical framework for precise genetic manipulation and can facilitate functional studies of genes that contribute to Mab physiology, antimicrobial resistance, and pathogenesis.
ER -